ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL
Author(s): de Vos AI, Nooter K, Verweij J, Loos WL, Brouwer E, de Bruijn P, Ruijgrok EJ, van der Burg MEL, Stoter G, Sparreboom A
Source: ANNALS OF ONCOLOGY    Volume: 8    Issue: 11    Pages: 1145-1150    Published: NOV 1997  
Times Cited: 14     References: 33     
Abstract: Background. Several clinical studies have shown that polychemotherapy with the taxanes paclitaxel or docetaxel preceded or followed by cisplatin is associated with important schedule-dependent differences in toxicities, such as leukocytopenia. In general, the pharmacokinetics of both drugs during the combined treatment are unaltered, suggesting that a pharmacodynamic interaction might have occurred.

Materials and methods: In order to gain insight into this pharmacologic interaction, we performed in vitro drug accumulation studies using peripheral blood leukocytes and a panel of tumor and non-malignant cell lines with paclitaxel and docetaxel, as wel as with their respective formulation vehicles Cremophor EL and Tween 80.

Results: Our results show a significant reduction in the intracellular cisplatin concentration in leukocytes of up to 42% in the presence of Cremophor EL and Tween 80 as compared to the control. This pharmacodynamic interaction of these surfactants with cisplatin seems to be specific for haematopoietic cells, and does not occur in solid tumor cells.

Conclusion: The present data suggest that the pharmaceutical vehicles Cremophor EL and Tween 80 might contribute to the reduced cisplatin-associated myelotoxicity observed in the clinical combination chemotherapy studies with paclitaxel and docetaxel.

Document Type: Article
Language: English
Reprint Address: Sparreboom, A (reprint author), Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, Lab Expt Chemotherapy Pharmacol & Tumor Biol, POB 5201, NL-3008 AE Rotterdam, Netherlands
Addresses:
1. Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, Lab Expt Chemotherapy Pharmacol & Tumor Biol, NL-3008 AE Rotterdam, Netherlands
2. Univ Rotterdam Hosp, NL-3008 AE Rotterdam, Netherlands
3. Erasmus Univ, Dept Clin Microbiol, Rotterdam, Netherlands
Publisher: KLUWER ACADEMIC PUBL, SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
Subject Category: Oncology
IDS Number: YL777
ISSN: 0923-7534
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo